Skip to content
GLP-1 Scorecard
Menu
Site position #332

Signos

Published by GLP-1 ScorecardUpdated

Signos (Signos+) is a metabolic-health platform that bundles clinician-prescribed compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor (CGM) and app — pairing the medication with real-time glucose data and coaching so users understand and sustain their weight loss.

Visit SignosWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$199/mo (6-month plan, compounded)
Tirzepatide
$199/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Not confirmed

Weigh Signos against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value44/100
Dose & formulation64/100
Clinical oversight84/100
Labs & monitoring71/100
Fulfillment71/100
Contract terms20/100

Strengths

  • Bundles compounded GLP-1 (semaglutide) with an FDA-cleared CGM and app — glucose-guided weight loss, not just medication
  • Starting at $199/mo on a 6-month program, with the CGM included at no extra cost
  • Free rapid shipping; HSA/FSA eligible
  • Real-time glucose insights and app coaching to help sustain results after GLP-1

What to consider

  • Compounded GLP-1s are not FDA-approved finished products
  • Headline price is a 6-month-program rate, not month-to-month
  • Only semaglutide is shown in the program; tirzepatide availability is not confirmed
  • Compounding pharmacy partner and state availability are not published on the landing page

Bottom line — Grade C

Best for: Shoppers who want pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app.

Site position #332 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Signos — the realistic shortlist.

The 19 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Signos's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Signos's site. Not medical advice; see our disclosure.

← Back to the scorecard